Most Read Articles
21 Feb 2021
The efficacy and safety of the two-bag (TB) system are comparable to those of the one-bag (OB) system in adults with diabetic ketoacidosis (DKA), results of a study have shown. Both approaches can be considered in adult DKA patients.
01 Dec 2020
Tetanus toxoid 5 Lf, diphtheria toxoid 2 Lf, pertussis toxoid 2.5 mcg, filamentous haemagglutinin 5 mcg, fimbriae types 2 and 3 5 mcg, pertactin 3 mcg
Dr. Hsu Li Yang, Dr. Tan Thuan Tong, Dr. Andrea Kwa, 08 Jan 2021
Antimicrobial resistance has become increasingly dire as the rapid emergence of drug resistance, especially gram-negative pathogens, has outpaced the development of new antibiotics. At a recent virtual symposium, Dr Hsu Li Yang, Vice Dean (Global Health) and Programme Leader (Infectious Diseases), NUS Saw Swee Hock School of Public Health, presented epidemiological data on multidrug-resistant (MDR) gram-negative bacteria (GNB) in Asia, while Dr Tan Thuan Tong, Head and Senior Consultant, Department of Infectious Diseases, Singapore General Hospital (SGH), focused on the role of ceftazidime-avibactam in MDR GNB infections. Dr Andrea Kwa, Assistant Director of Research, Department of Pharmacy, SGH, joined the panel in an interactive fireside chat, to discuss challenges, practical considerations, and solutions in MDR gram-negative infections. This Pfizer-sponsored symposium was chaired by Dr Ng Shin Yi, Head and Senior Consultant of Surgical Intensive Care, SGH.
05 Feb 2021

Primary immunodeficiency disease (PIDD) and allergies are two groups of conditions related to the immune system. However, they are uniquely different in terms of symptoms and treatment.

Genetic underpinnings of severe, life-threatening COVID-19 uncovered

Tristan Manalac
20 Feb 2021

The propensity of the novel coronavirus disease (COVID-19) to develop into a severe and life-threatening disease appears to be influenced by genetics, according to the GenOMICC* study, whose results were recently presented at the eCritical Care Reviews Meeting 2021 (eCCR21).

“There is always variability in susceptibility to infection,” said Kenneth Baillie, leader of GenOMICC. “There are multiple biological factors underlying that, but some of it is genetic.”

This analysis sought to identify key genes and molecules regarding COVID-19 and open up new therapeutic avenues.

The researchers first searched for genetic signals in 2,244 critically ill COVID-19 patients, enrolled from 208 UK intensive care units. Using ancestry-matched controls, while excluding individuals with known COVID-19 exposure, a genome-wide association study (GWAS) identified 15 independent genetic signals, with p-value <5×10–8. [Nature 2020;doi:10.1038/s41586-020-03065-y]

Of these, eight were successfully validated in a subsequent GWAS that used two independent population genetic studies as controls.

To further refine the list of potential genetic targets, the researchers replicated their findings in a meta-analysis of data from 2,415 hospitalized COVID-19 patients, retrieved from the COVID-19 Host Genetics Initiative, along with 1,128 cases from 23andMe. A total of 477,741 and 679,531 unexposed controls were also enrolled from the respective data sources.

Ultimately, five genetic signals emerged significant in both the initial GWAS and subsequent replication studies. These included specific loci in or around the OAS gene cluster, and the TYK2, DPP9, CCR2, and IFNAR2 genes.

“Our findings reveal that critical illness in COVID-19 is related to at least two biological mechanisms: innate antiviral defences, which are known to be important early in disease (IFNAR2 and OAS genes), and host-driven inflammatory lung injury, which is a key mechanism of late, life-threatening COVID-19 (DPP9, TYK2, and CCR2),” the researchers explained.

Mendelian randomization further revealed a causal effect of the IFNAR2 gene on the likelihood of developing severe or life-threatening COVID-19. Particularly, enhanced expression of its resulting interferon receptor subunit protein significantly reduced the odds of such an outcome.

While the other genetic loci failed to demonstrate significance in Mendelian randomization, their known biological functions nevertheless support their potential roles in COVID-19 disease course. OAS genes, for instance, form part of the pathway that culminates in the activation of RNAse L, an enzyme that can degrade double-stranded RNA, which coronaviruses use as a replication intermediate. [Exp Mol Med 2015;47:e144; J Virol 2012;86:5808-5816]

“Genetics can potentially lead us to new treatments. That’s fundamentally the reason for doing all of this work and that’s why clinicians should be interested,” said Baillie, referring to the GenOMICC study.

“This is the work of an absolutely colossal number of people who really did all work very, very hard to make it happen,” he added.

*Genetics of mortality in critical care

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
21 Feb 2021
The efficacy and safety of the two-bag (TB) system are comparable to those of the one-bag (OB) system in adults with diabetic ketoacidosis (DKA), results of a study have shown. Both approaches can be considered in adult DKA patients.
01 Dec 2020
Tetanus toxoid 5 Lf, diphtheria toxoid 2 Lf, pertussis toxoid 2.5 mcg, filamentous haemagglutinin 5 mcg, fimbriae types 2 and 3 5 mcg, pertactin 3 mcg
Dr. Hsu Li Yang, Dr. Tan Thuan Tong, Dr. Andrea Kwa, 08 Jan 2021
Antimicrobial resistance has become increasingly dire as the rapid emergence of drug resistance, especially gram-negative pathogens, has outpaced the development of new antibiotics. At a recent virtual symposium, Dr Hsu Li Yang, Vice Dean (Global Health) and Programme Leader (Infectious Diseases), NUS Saw Swee Hock School of Public Health, presented epidemiological data on multidrug-resistant (MDR) gram-negative bacteria (GNB) in Asia, while Dr Tan Thuan Tong, Head and Senior Consultant, Department of Infectious Diseases, Singapore General Hospital (SGH), focused on the role of ceftazidime-avibactam in MDR GNB infections. Dr Andrea Kwa, Assistant Director of Research, Department of Pharmacy, SGH, joined the panel in an interactive fireside chat, to discuss challenges, practical considerations, and solutions in MDR gram-negative infections. This Pfizer-sponsored symposium was chaired by Dr Ng Shin Yi, Head and Senior Consultant of Surgical Intensive Care, SGH.
05 Feb 2021

Primary immunodeficiency disease (PIDD) and allergies are two groups of conditions related to the immune system. However, they are uniquely different in terms of symptoms and treatment.